Claritev Cleared of Criminal Antitrust Charges by DOJ
Summary
Claritev announced the Department of Justice has closed its criminal antitrust grand jury proceeding, confirming the company is not a criminal target. This significantly de-risks the company, removing a major overhang that was previously disclosed in an 8-K on May 18th regarding an ongoing probe. While the criminal investigation is closed, Claritev is still cooperating with a civil investigative demand received on May 19th. The focus now shifts to the outcome of the civil matter.
At the time of this announcement, CTEV was trading at $28.77 on NYSE in the Life Sciences sector, with a market capitalization of approximately $484.8M. The 52-week trading range was $11.50 to $74.07. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Wiseek News.